Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Na Hyea Kang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Brain Research|January 8, 2016
Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's diseaseCandace H Carriere, Na Hyea Kang, Lennard P Niles
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|December 18, 2016
Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatmentCandace H Carriere, Na Hyea Kang, Lennard P Niles
Basic & Clinical Pharmacology & Toxicology|January 28, 2014
Induction of neurotrophic and differentiation factors in neural stem cells by valproic acidWalaa Almutawaa, Na Hyea Kang, Yi Pan, et al.
Brain Research|October 4, 2016
Altered melatonin MT<sub>1</sub> receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundleNa Hyea Kang, Candace H Carriere, Sarra G Bahna, et al.
The International Journal of Neuropsychopharmacology|January 17, 2012
Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brainLennard P Niles, Arani Sathiyapalan, Sarra Bahna, et al.
Molecular Brain|September 3, 2011
Impaired spatial and contextual memory formation in galectin-1 deficient miceMasanori Sakaguchi, Maithe Arruda-Carvalho, Na Hyea Kang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 23, 2012
HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferationAngie Yeung, Rishi K Bhargava, Raphael Ahn, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Brain Research|January 8, 2016
Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's diseaseCandace H Carriere, Na Hyea Kang, Lennard P Niles
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|December 18, 2016
Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatmentCandace H Carriere, Na Hyea Kang, Lennard P Niles
Basic & Clinical Pharmacology & Toxicology|January 28, 2014
Induction of neurotrophic and differentiation factors in neural stem cells by valproic acidWalaa Almutawaa, Na Hyea Kang, Yi Pan, et al.
Brain Research|October 4, 2016
Altered melatonin MT<sub>1</sub> receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundleNa Hyea Kang, Candace H Carriere, Sarra G Bahna, et al.
The International Journal of Neuropsychopharmacology|January 17, 2012
Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brainLennard P Niles, Arani Sathiyapalan, Sarra Bahna, et al.
Molecular Brain|September 3, 2011
Impaired spatial and contextual memory formation in galectin-1 deficient miceMasanori Sakaguchi, Maithe Arruda-Carvalho, Na Hyea Kang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 23, 2012
HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferationAngie Yeung, Rishi K Bhargava, Raphael Ahn, et al.
Pageof 1